No abstract available
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Age Factors
-
Aged
-
Alendronate / therapeutic use
-
Calcitonin / therapeutic use
-
Calcium Channel Blockers / therapeutic use
-
Calcium, Dietary / therapeutic use
-
Dietary Supplements
-
Drug Therapy, Combination
-
Estrogens / deficiency
-
Etidronic Acid / analogs & derivatives
-
Etidronic Acid / therapeutic use
-
Exercise
-
Female
-
Hormone Replacement Therapy
-
Humans
-
Male
-
Middle Aged
-
Osteoporosis* / diagnosis
-
Osteoporosis* / diet therapy
-
Osteoporosis* / drug therapy
-
Osteoporosis* / prevention & control
-
Raloxifene Hydrochloride / therapeutic use
-
Risedronic Acid
-
Risk Assessment
-
Risk Factors
-
Selective Estrogen Receptor Modulators / therapeutic use
-
Vitamin D / therapeutic use
Substances
-
Calcium Channel Blockers
-
Calcium, Dietary
-
Estrogens
-
Selective Estrogen Receptor Modulators
-
Vitamin D
-
Raloxifene Hydrochloride
-
Calcitonin
-
Risedronic Acid
-
Etidronic Acid
-
Alendronate